Persistent URL of this record https://hdl.handle.net/1887/88286
In Collections
This item can be found in the following collections:
![NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS
- All authors
- Klein, M.; Reijneveld, J.C.; Idbaih, A.; Taal, W.; Clement, P.M.; Vos, F. de; Wick, A.; Mulholland, P.; Taphoorn, M.J.B.; Lewis, J.; Weller, M.; Verschuere, T.; Golfinopoulos, V.; Gorlia, T.; Bent, M. van den
- Date
- 2017-11-30
- Journal
- Neuro-Oncology
- Volume
- 19
- Pages
- 139 - 139